Sangamo Therapeutics (SGMO)
NASDAQ:SGMO
Want to see SGMO full AI Analyst Report?
Sangamo Therapeutics (SGMO) Ownership Overview
1.13% Insiders
4.84% Mutual Funds
0.27% Other Institutional Investors
3.92% ETFs
89.84% Public Companies and
Individual Investors
The ownership structure of Sangamo Therapeutics (SGMO) stock is a mix of institutional, retail, and individual investors. Approximately 9.03% of the company’s stock is owned by Institutional Investors, 1.13% is owned by Insiders, and 89.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 23, 2026 | xxxxxxxxxxxxx | $17457 | |
Apr 23, 2026 | xxxxxxxxxxxxx | $86486 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Sep 30, 2023 | xxxxxxxxxxxxx | $135172 | |
Sep 30, 2023 | xxxxxxxxxxxxx | $435012 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,415,555 | Institution | 3.00% | 1,676,100 | |
| 9,593,688 | Institution | 2.32% | 1,295,148 | |
| 4,688,930 | Institution | 1.13% | 633,006 | |
| 3,194,716 | Institution | 0.77% | 431,287 | |
| 2,053,215 | Institution | 0.50% | 277,184 | |
| 1,907,656 | Insider | 0.46% | 257,534 | |
| 1,200,000 | Institution | 0.29% | 162,000 | |
| 1,050,465 | Institution | 0.25% | 141,813 | |
| 1,035,742 | Institution | 0.25% | 139,825 | |
| 660,042 | Insider | 0.16% | 89,106 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,593,688 | Institution | 2.32% | 1,295,148 | |
| 4,688,930 | Institution | 1.13% | 633,006 | |
| 3,194,716 | Institution | 0.77% | 431,287 | |
| 1,200,000 | Institution | 0.29% | 162,000 | |
| 657,047 | Institution | 0.16% | 88,701 | |
| 186,285 | Institution | 0.04% | 25,148 | |
| 177,187 | Institution | 0.04% | 23,920 | |
| 102,568 | Institution | 0.02% | 13,847 | |
| 54,511 | Institution | 0.01% | 7,359 | |
| 49,405 | Institution | 0.01% | 6,670 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,956,969 | Institution | 1.92% | 1,964,576 | |
| 4,458,586 | Institution | 1.08% | 1,100,825 | |
| 1,799,207 | Institution | 0.43% | 214,465 | |
| 881,181 | Institution | 0.21% | 118,959 | |
| 328,312 | Institution | 0.08% | 39,135 | |
| 261,859 | Institution | 0.06% | 31,214 | |
| 254,008 | Institution | 0.06% | 30,278 | |
| 169,284 | Institution | 0.04% | 22,853 | |
| 102,746 | Institution | 0.02% | 12,247 | |
| 21,725 | Institution | <0.01% | 2,933 |
FAQ
Who Owns Sangamo Therapeutics (SGMO)?
According to the latest TipRanks data, approximately 0.27% of the company's stock is held by institutional investors, 1.13% is held by insiders, and 89.84% is held by retail investors.
What percentage of Sangamo Therapeutics (SGMO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.27% of Sangamo Therapeutics (SGMO) stock is held by institutional investors.
What percentage of Sangamo Therapeutics (SGMO) stock is held by retail investors?
According to the latest TipRanks data, approximately 89.84% of Sangamo Therapeutics (SGMO) stock is held by retail investors.
Who owns the most shares of Sangamo Therapeutics (SGMO)?
Vanguard owns the most shares of Sangamo Therapeutics (SGMO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.